Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:41 pm Purchase | 2026-03-31 | 13G | KEROS THERAPEUTICS INC KROS | Nantahala Capital Management, LLC | 1,360,419 6.900% | 1,360,419 (New Position) | Filing History |
| 2026-04-07 12:39 pm Sale | 2026-03-31 | 13G | KEROS THERAPEUTICS INC KROS | BlackRock, Inc. BLK | 1,990,842 10.100% | -45,946 (-2.26%) | Filing History |
| 2026-03-27 10:16 am Sale | 2026-03-13 | 13G | KEROS THERAPEUTICS INC KROS | VANGUARD GROUP INC | 0 0.000% | -1,525,355 (Position Closed) | Filing History |
| 2026-02-17 5:17 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | ExodusPoint Capital Management LP | 13,360 0.040% | -1,894,539 (-99.30%) | Filing History |
| 2026-02-17 4:52 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | Madison Avenue International LP | 823,707 2.700% | -1,790,695 (-68.49%) | Filing History |
| 2026-02-17 4:15 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | TANG CAPITAL MANAGEMENT, LLC | 0 0.000% | -2,418,984 (Position Closed) | Filing History |
| 2026-02-17 4:05 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | D. E. Shaw & Co., L.P. | 756,156 3.900% | -789,792 (-51.09%) | Filing History |
| 2026-01-30 2:17 pm Sale | 2025-12-31 | 13G | KEROS THERAPEUTICS INC KROS | VANGUARD GROUP INC | 1,525,355 5.000% | -1,040,966 (-40.56%) | Filing History |
| 2025-11-18 4:07 pm Purchase | 2025-11-10 | 13G | KEROS THERAPEUTICS INC KROS | ExodusPoint Capital Management LP | 1,907,899 6.300% | 1,907,899 (New Position) | Filing History |
| 2025-10-27 4:05 pm Purchase | 2025-10-20 | 13G | KEROS THERAPEUTICS INC KROS | D. E. Shaw & Co., L.P. | 1,545,948 5.100% | 1,545,948 (New Position) | Filing History |
| 2025-10-22 9:26 pm Purchase | 2025-10-15 | 13G | KEROS THERAPEUTICS INC KROS | TANG CAPITAL MANAGEMENT, LLC | 2,418,984 7.900% | 2,418,984 (New Position) | Filing History |
| 2025-10-16 5:36 pm Sale | 2025-10-15 | 13D | KEROS THERAPEUTICS INC KROS | Pontifax VI G.P. L.P. | 0 0.000% | -4,787,331 (Position Closed) | Filing History |
| 2025-10-15 06:50 am Sale | 2025-10-15 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management, LLC | 0 0.000% | -5,389,264 (Position Closed) | Filing History |
| 2025-08-21 4:15 pm Sale | 2025-08-21 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management, LLC | 5,389,264 13.270% | -1,700 (-0.03%) | Filing History |
| 2025-05-14 5:49 pm Purchase | 2025-05-07 | 13G | KEROS THERAPEUTICS INC KROS | Madison Avenue International LP | 2,614,402 6.400% | 2,614,402 (New Position) | Filing History |
| 2025-05-12 11:29 am Unchanged | 2025-05-12 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management, LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-05-08 4:39 pm Unchanged | 2025-05-08 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management, LLC | 5,390,964 13.270% | 0 (Unchanged) | Filing History |
| 2025-05-05 2:03 pm Sale | 2025-04-30 | 13G | KEROS THERAPEUTICS INC KROS | JPMorgan Chase & Co. JPM | 113,803 0.200% | -2,473,343 (-95.60%) | Filing History |
| 2025-05-02 09:59 am Purchase | 2025-03-31 | 13G | KEROS THERAPEUTICS INC KROS | JPMorgan Chase & Co. JPM | 2,587,146 6.300% | 2,587,146 (New Position) | Filing History |
| 2025-04-30 11:23 am Purchase | 2025-03-31 | 13G | KEROS THERAPEUTICS INC KROS | VANGUARD GROUP INC | 2,566,321 6.320% | 2,566,321 (New Position) | Filing History |